Cover Image

Epidemiology of Progressive Supranuclear Palsy in Navarre, Spain: A Population‐Based Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	P. Arrondo Gómez, E. Vicente, G. Martí‐Andrés, J. Sánchez Ruiz de Gordoa, I. Gastón, P. Clavero, R. Valentí, J. Delfrade, M. E. Erro
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	European Journal of Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of Mitochondrial DNA Copy Number in Progressive Supranuclear Palsy Patients: Evidence From a Pilot Study
by: Luigi Citrigno, et al.
Published: (2026)

In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy
by: Kosei Hirata, et al.
Published: (2024)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
by: Roxane Dilcher, et al.
Published: (2026)

Brainstem and Cerebellar Volume Loss and Associated Clinical Features in Progressive Supranuclear Palsy
by: Chloe Spiegel, et al.
Published: (2026)

Evaluating the Effect of Alzheimer's Disease‐Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy
by: Indira Garcia‐Cordero, et al.
Published: (2024)

MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology
by: Sophie Voase, et al.
Published: (2026)

Risk Factors Associated With Bell's Palsy: A Real‐World Analysis of 281,600 Patients
by: Norbert Neckel, et al.
Published: (2025)

Understanding Parkinson disease in Spain: Genetic and clinical insights
by: Pilar Gómez‐Garre, et al.
Published: (2024)

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study
by: P. Corcia, et al.
Published: (2025)

Epidemiology and Economic Burden of Sleep Disorders in Europe
by: Claudio L. A. Bassetti, et al.
Published: (2026)

Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
by: Vitor Maia Arca, et al.
Published: (2026)

Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population
by: Elisa Demicheli, et al.
Published: (2025)

Erythrocyte Fragility in Progressive Multiple Sclerosis
by: Carmen Jacob, et al.
Published: (2026)

Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery
by: Elvira Immacolata Parrotta, et al.
Published: (2025)

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis
by: Nicolás Fissolo, et al.
Published: (2026)

Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain
by: Luis Querol, et al.
Published: (2026)

Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl‐L‐Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain
by: Mattia Cominacini, et al.
Published: (2025)

Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS
by: Katelijn M. Blok, et al.
Published: (2025)

Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa
by: Francesca Morgante, et al.
Published: (2025)

Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke
by: Alicia Sierra‐Gómez, et al.
Published: (2024)

Epilepsy Management in Transgender Population: More Research for Better Treatment
by: Bruna Nucera, et al.
Published: (2025)

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis
by: Ferdinando Clarelli, et al.
Published: (2025)

Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech
by: Nadia Hossain, et al.
Published: (2025)

Angiographic Characteristics and Progression in A Comprehensive Nationwide European MOYAMOYA Cohort
by: Peter Birkeland, et al.
Published: (2025)

Cerebral amyloid angiopathy decades after red blood cell transfusions: a report of two cases from a prospective cohort
by: K. Kaushik, et al.
Published: (2024)

Diagnostic Yield and Genotype–Phenotype Correlations of Clinical Exome Sequencing in Hereditary Spastic Paraparesis: Experience From Eastern Spain
by: Lidón Carretero‐Vilarroig, et al.
Published: (2026)

ITPR3‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease
by: Javier Cabello‐Murgui, et al.
Published: (2024)

Natural Progression of Pineal Cysts in Relation to Headache: A Prospective Observational Study
by: Victor Hvingelby, et al.
Published: (2025)

Applicability and Correlates of a Symptom‐Led Staging System for Primary Progressive Aphasia
by: Edoardo Nicolò Aiello, et al.
Published: (2025)

Comment on: Associations of Inflammatory Markers With Neurological Dysfunction and Prognosis in Patients With Progressive Stroke
by: Xinmin Zhao, et al.
Published: (2025)

Monoclonal Gammopathy in Amyotrophic Lateral Sclerosis: No Impact on Clinical Progression and Immunotherapy Outcomes
by: Hyunkee Kim, et al.
Published: (2025)

Letter to the Editor: “Record‐Linkage in Population Studies on Epilepsy: Pros and Cons”
by: Lorenzo Muccioli, et al.
Published: (2025)

Three‐Objects‐Three‐Places Episodic Memory Test to Screen Mild Cognitive Impairment and Mild Dementia: Validation in a Memory Clinic Population
by: Federica Ribaldi, et al.
Published: (2025)

Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants
by: Edoardo Gioele Spinelli, et al.
Published: (2025)

Cortisol and 10‐Year Cognitive Decline in Older People From the General Population
by: Simone Amendola, et al.
Published: (2025)

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain
by: Pilar H. García‐Casanova, et al.
Published: (2024)

Sex Differences in the Association Between Physical Functioning and Cognition in Two Central European Populations
by: Tatyana Court, et al.
Published: (2025)

“Spanish flu,” encephalitis lethargica, and COVID‐19: Progress made, lessons learned, and directions for future research
by: Michael Brainin, et al.
Published: (2024)

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis
by: Igal Rosenstein, et al.
Published: (2026)

Population‐Based Versus Hospital‐Based Data in Amyotrophic Lateral Sclerosis—A Factor to Consider?
by: Johannes Dorst, et al.
Published: (2025)